You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
瑞科生物-B(02179.HK)擬參與H股全流通計劃
格隆匯 05-21 17:39

格隆匯5月21日丨瑞科生物-B(02179.HK)發佈公吿,董事會已於2025年5月21日審議批准,擬將公司約1.42億股未上市股份轉換為公司H股(“本次H股全流通”)。在取得所有相關備案及批准(包括中國證監會備案及聯交所批准)及符合所有適用的法律、規則及法規後,有關未上市股份將被轉換為H股,公司將向聯交所申請該等H股於主板上市及買賣(“轉換及上市”)。

此外,董事會於2025年5月21日召開董事會會議,選舉陳青青擔任第二屆董事會提名委員會委員。陳青青的任期自董事會審議通過之日起,至第二屆董事會屆滿之日止。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account